Meeting NewsVideo

VIDEO: Novaliq aims for water-free drop drug delivery to improve safety, tolerability

NEW ORLEANS ― At the Ophthalmology Innovation Summit here, Christian Roesky, PhD, managing director and CEO of Novaliq, discusses the company’s research into combining pharmaceuticals with its water-free EyeSol technology for enhanced drug delivery to the eye.

NEW ORLEANS ― At the Ophthalmology Innovation Summit here, Christian Roesky, PhD, managing director and CEO of Novaliq, discusses the company’s research into combining pharmaceuticals with its water-free EyeSol technology for enhanced drug delivery to the eye.

    See more from Ophthalmology Innovation Summit